Drugs.com - Pharma Industry News

Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa

WEDNESDAY, June 25, 2025 -- For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene zamikeracel, an autologous COL7A1 gene-modified cellular sheet that is sutured onto a large, chronic...

Jun 25, 2025 - 19:05
 0
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
WEDNESDAY, June 25, 2025 -- For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene zamikeracel, an autologous COL7A1 gene-modified cellular sheet that is sutured onto a large, chronic...
Read More

Tags:

Previous Article

Desogestrel for More Than Five Years May Up Risk of Intracranial Meningioma

Next Article

Paternal Mental Distress Linked to Poorer Offspring Development

Related Posts

ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced Breast Cancer With ESR1 Mutations

ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced...

Jun 2, 2025  0

Epilepsy More Common With Frontotemporal Dementia

Epilepsy More Common With Frontotemporal Dementia

Jun 10, 2025  0

Almost One-Quarter of U.S. Firearm Suicides May Occur Outside the Home

Almost One-Quarter of U.S. Firearm Suicides May Occur O...

Jun 12, 2025  0